Atlas Trials

Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children

Clinical trial NCT02339350 · UNKNOWN

Trial details

NCT number
NCT02339350
Sponsor
The Korean Society of Pediatric Hematology Oncology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaChild
Start date
2015-01-01
Primary completion
2023-04-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.